News

28/06/2023

AMR Industry Alliance Opens Applications for 2023 Stewardship Prize

The AMR Industry Alliance is pleased to announce that is now accepting applications for its annual Stewardship Prize. The Stewardship Prize is an initiative to identify and recognize innovative approaches to combatting antimicrobial resistance (AMR) in low-to-moderate-income countries

Read more
22/06/2023

AMR Certification: Recognising Responsibly in Antibiotic Manufacture

Following the recent launch of the BSI’s AMR certification, EPR invited Steve Brooks from the AMR Industry Alliance and BSI’s Courtney Soulsby to elucidate its significance for antibiotic manufact...

Read more
06/06/2023

New AMR Certification Launched for Antibiotic Manufacturers

  Following publication of the Antibiotic Manufacturing Standard in 2022 to help overcome AMR, antibiotic manufacturers can now verify their actions through a new certification.   This...

Read more
05/06/2023

To Push Antibiotic Makers to Be More Green, a New System Will Certify Manufacturing Practices

  This article first appeared in STAT. In response to concerns about pollution caused by antibiotic production, an industry group is launching a new system to certify that manufacturers mee...

Read more
05/06/2023

New Certification System Could Promote Responsible Antibiotic Manufacturing

  This article was originally published by the Center for Infectious Disease Policy and Research (CIDRAP).   A new certification scheme launched today aims to minimize the environ...

Read more
05/06/2023

Verifying Antibiotics Supply Chain Standards

  This article was originally published in POLITICO Pro Morning Health Care. From today, manufacturers of antibiotics and their raw ingredients can apply for a new certificate that proves t...

Read more
05/06/2023

AMR Alliance Follows Up Global Industry Standard With Responsible Manufacturing Certification

  BSI Certification Is Open To Any Manufacturer, For Any Drug Executive Summary A new voluntary certification from the AMR Industry Alliance and the British Standards Institution will asse...

Read more
05/06/2023

New Certification Aims to Mitigate Antimicrobial Resistance in Antibiotic Manufacturing

Certification launched to demonstrate the responsible manufacturing of antibiotics and address environmental waste concerns LONDON, June 5, 2023 /PRNewswire/ -- BSI, the business improvement...

Read more
05/06/2023

New Certification Aims to Mitigate Antimicrobial Resistance Risk in Antibiotic Manufacturing

Certification launched to demonstrate the responsible manufacturing of antibiotics and address environmental waste concerns London, UK -- BSI, the business improvement and standards company, today...

Read more
24/05/2023

Pollution from Antibiotic Factories Highlighted as Public Health Risk

This article first appeared in the Financial Times When some public-spirited Indian military veterans decided to examine the water quality in the Sirsa and Sutlej rivers, in the northern state of H...

Read more
24/05/2023

AMR Industry Alliance Releases 2022 Annual Report

New York, NY The AMR Industry Alliance is pleased to release its 2022 Annual Report, a summary of work undertaken by the Alliance and its members this year to curb the rise of antimicrobial resista...

Read more
19/04/2023

AMR Stewardship Prize Winner Spotlight: Ghana’s Lekma Hospital

Antimicrobial resistance, a top 10 global public health threat, is often exacerbated by the misuse and misdiagnosis of antimicrobials by patients. At Lekma Hospital, a local hospital in Accra, Ghana,...

Read more
06/04/2023

AMR Stewardship Prize Winner Spotlight: Pakistan’s Clinical Engagement Program

Antimicrobial resistance (AMR) is a silent killer spreading across the globe at an alarming rate, leaving healthcare systems struggling to keep up. Pakistan is no exception, with limited resources and...

Read more
15/02/2023

Strengthening the Sustainability of the Off-Patent Antibiotic Supply Chain

February 15, 2023 – The AMR Industry Alliance today announced the publication of its report, “Strengthening the Sustainability of the Off-Patent Antibiotic Supply Chain,” which investigates the...

Read more
21/12/2022

AMR Industry Alliance Awards Annual Stewardship Prize to Lekma Hospital in Ghana and the Clinical Engagement Program in Pakistan

Prize recognizes innovative and scalable stewardship programs in low-to-moderate-income countries. Geneva – December 21, 2022 – The AMR Industry Alliance, the leading life-sciences coalition s...

Read more
29/10/2022

Steve Brooks Speaks on Quadripartite Webinar on Ways to Prevent and Control AMR in the Environment

The Quadripartite, the Food and Agriculture Organization of the United Nations (UNFAO), the United Nations Environment Programme (UNEP), the World Health Organization (WHO) and the World Organisation...

Read more
12/07/2022

New Report on Drug Regulatory Approvals and the Opportunities for Antimicrobial Innovation

  JULY 12, 2022 – A new report by the One Health Trust, Drug Regulatory Approvals and Opportunities for Antimicrobial Innovation - Perspectives from Brazil, India and South Africa, describes...

Read more
13/06/2022

AMR Industry Alliance Launches Antibiotic Manufacturing Standard to Help Mitigate the Impacts of Antimicrobial Resistance

Standard provides guidance, calls on manufacturers to improve waste management programs. Geneva – June 14, 2022 – The AMR Industry Alliance, the largest life-sciences coalition set up to provide...

Read more
05/05/2022

Health Europa Quarterly Issue 21 Explores AMR

Health Europa Quarterly has published its twenty-first issue which features AMR, as well as the AMR Industry Alliance's Progress Report, acknowledging "the urgent need to facilitate a sustainable mark...

Read more
06/04/2022

2022 Stewardship Prize: Now Accepting Submissions

    While significant efforts have been initiated across low- and middle-income countries (LMICs) to address AMR stewardship and appropriate use of antibiotics, limited resources exist...

Read more
23/11/2021

Stewardship Prize Winner Announced

Prize Winner: Infectious Diseases Institute - Kampala, Uganda After careful review, the AMR Industry Alliance is proud to announce the Infectious Diseases Institute (IDI) in Kampala, Uganda as the...

Read more
22/11/2021

Thomas Cueni

Building Health System Resilience: The Role of Antimicrobials A video series celebrating World Antimicrobial Awareness Week 2021   “We all have a shared responsibility to find ways f...

Read more
22/11/2021

Dr. John Rex

Building Health System Resilience: The Role of Antimicrobials A video series celebrating World Antimicrobial Awareness Week 2021   “Antibiotics only have a finite lifetime. We only g...

Read more
22/11/2021

Manjit Singh

Building Health System Resilience: The Role of Antimicrobials A video series celebrating World Antimicrobial Awareness Week 2021   “The AMR Industry Alliance is making a next big ste...

Read more
22/11/2021

Dr. Larry Kerr

Building Health System Resilience: The Role of Antimicrobials A video series celebrating World Antimicrobial Awareness Week 2021   "Public-private partnerships are one of the invaluabl...

Read more
18/11/2021

Dr. Manica Balasegaram

Building Health System Resilience: The Role of Antimicrobials A video series celebrating World Antimicrobial Awareness Week 2021 "New treatments will only be successful if they are available t...

Read more
18/11/2021

Dr. Ramanan Laxminarayan

Building Health System Resilience: The Role of Antimicrobials A video series celebrating World Antimicrobial Awareness Week 2021   “We certainly aren’t where we need to be with res...

Read more
09/11/2021

World Antimicrobial Awareness Week (WAAW) 2021

As part of this year’s World Antimicrobial Awareness Week (WAAW) the AMR Industry Alliance will host a virtual panel session on Supporting the optimal use of antimicrobial medicines through inno...

Read more
26/08/2021

Request for Proposals: Developing a sustainability framework for off-patent antibiotics

The AMR Industry Alliance is currently seeking proposals to support the work of its Access Working Group. The duration of this consultancy is defined for a period of approximately 6 months, starting 22 October 2021 (or as soon as the procurement process is completed) and ending 28 February 2022 when the deliverables have been approved by the AMR Industry Alliance Board. The consultancy will be conducted under the overall guidance of the AMR Industry Alliance Access Working Group Lead and Core Team. The Consultancy will be home-based, from any country.

Read more
21/06/2021

Request for Proposals: Regulatory Landscape Phase 1

  To view as a PDF, click here. Overview The AMR Industry Alliance is one of the largest private sector coalitions established to provide sustainable solutions to curb antimicrobial resist...

Read more
21/06/2021

Request for Proposals: Regulatory Landscape Phase 2

  To view as a PDF, click here. Overview   The AMR Industry Alliance is one of the largest private sector coalitions established to provide sustainable solutions to curb antimicrob...

Read more
20/06/2021

Stewardship Prize: Strengthening Stewardship and Appropriate Use in Low- and Middle-Income Countries

About the Stewardship Prize While significant efforts have been initiated across low- and middle-income countries (LMICs) to address AMR stewardship and appropriate use of antibiotics, limited resour...

Read more
16/01/2020

AMR life sciences industry 2020 report: Successes and setbacks in fighting superbugs 

 AMR Industry Alliance reports breakthroughs in the responsible manufacturing of antibiotics and positive steps to improve how patients access and use antibiotics. But its report also highlights conc...

Read more
18/11/2019

AMR Industry Alliance Round-Up, Issue No.3, November 2019

Welcome to the third issue of the Alliance Round-Up – written for more than 100 biotech, diagnostic, generic and R&D pharma companies that are members of the AMR Industry Alliance, as well as p...

Read more
18/09/2019

AMR Industry Alliance Round-Up, Issue No.2, September 2019

Welcome to the second issue of the Alliance Round-Up – written for more than 100 biotech, diagnostic, generic and R&D pharma companies that are members of the AMR Industry Alliance, as well as...

Read more
29/07/2019

New brochure to discover the AMR Industry Alliance in 2 minutes

Representing more than 100 biotechnology, diagnostics, generics and research-based pharmaceutical companies and associations, the AMR Industry Alliance is one of the largest private sector coalitions...

Read more
13/06/2019

AMR Industry Alliance Round-Up, Issue No.1, June 2019

  This is the first issue of "Alliance Round-Up" written for the more than 100 biotech, diagnostic, generic and pharma companies who are members of the AMR Industry Alliance, as well as people...

Read more
12/11/2018

The largest private sector coalition to provide sustainable solutions to curb antimicrobial resistance (AMR) has made strides in 2018 and calls for a coordinated and multi-pronged response from all stakeholders

The largest private sector coalition to provide sustainable solutions to curb antimicrobial resistance (AMR) has made strides in 2018 and calls for a coordinated and multi-pronged response from all st...

Read more
08/06/2018

Multiple Alliance Members Co-sign the Canadian Declaration on Antimicrobial Resistance

The International Council of Biotechnology Associations (ICBA) supports the Canadian Declaration on Combatting Antimicrobial Resistance, signed by biopharmaceutical and diagnostic companies in Canada...

Read more
18/01/2018

Report shows life sciences industry alliance is taking action to curb antimicrobial resistance, with more to come

The new AMR Industry Alliance of more than 100 biotech, diagnostics, generics and research-based biopharmaceutical companies and trade associations launches its first progress report today. The re...

Read more
18/05/2017

New Alliance to Drive and Measure Industry Progress to Curb Antimicrobial Resistance

New Industry Alliance brings together research-based pharmaceutical companies, generics, biotech and diagnostic companies, to drive and measure industry progress to curb antimicrobial resistance....

Read more
20/09/2016

AMR Roadmap Launched

Leading Pharmaceutical Companies Present Industry Roadmap to Combat Antimicrobial Resistance Comprehensive roadmap lays out key commitments the pharmaceutical companies pledge to deliver by 2020...

Read more
21/01/2016

AMR Declaration Launched

More than 80 leading international pharmaceutical, generics, diagnostics and biotechnology companies, as well as key industry bodies, have come together to call on governments and industry to work in...

Read more